Baseline: Interpret BRCA1/BRCA2 germline variants
Baseline of Interpret BRCA1/BRCA2 germline variants
BayesDel under the ENIGMA specification
Baseline method for the use case, reviewed against its cited sources.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
18 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Claimed field baseline Context-only references | ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field baseline Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Method ids1 values
| ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Method ids1 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records3 values
| ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records3 values
| Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record. Context-only references | ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record. Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Context-only references | ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Source location uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Context-only references | Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4) Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024 final article; reported VCEP specifications v1.0 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-adc15377fab2 · Record review: source checked
2 source records and release history
- Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Original source · 2024 final article; reported VCEP specifications v1.0
- ACMG/AMP interpretation of BRCA1 missense variants: Structure-informed scores add evidence strength granularity to the PP3/BP4 computational evidence · Original source · American Journal of Human Genetics 112(5):993, published 2025; PMC12120176 full-text XML
Technical metadata and extraction receipts
Stable ID: use-case-baseline-brca1-brca2-germline-interpretation
- field
- baseline
- value
- BayesDel under the ENIGMA specification
- source locator
- uc-clinical-20260930-source-enigma: Results, computational evidence (BayesDel selection) and Table 2 (BayesDel cutpoints); brca-20261009-source-ramadane2025: Abstract and Introduction (ENIGMA VCEP use of the meta-predictor BayesDel for PP3/BP4)
- method ids
- uc-clinical-20260930-method-bayesdel
- rationale
- The ClinGen ENIGMA BRCA1/BRCA2 specification uses BayesDel, with gene-specific cutpoints, as its computational evidence for missense variants (PP3/BP4), so a new predictor is judged against it. BayesDel is a meta-predictor that combines other scores, so it is a simple trained model rather than a pre-machine-learning method; manual review under the specification, the full comparator, has no method record.
- review
- method: source-hash-verification; automated-source-review; reviewer: claude; reviewer note: Separate Claude review agent, independent of the agent that proposed the baseline; no human review claimed; reviewed at: 2026-10-12T18:00:00Z; note: Reviewer corrected rationale. Sources re-retrieved and read; method records and their configuration links checked against the use case's active comparisons. Names the reference newer methods are compared with, not a recommendation. See docs/reviews/use-cases/baselines-2026-10-12.md.
- pins
- record id: brca-20261009-source-ramadane2025; fields: status; attributes.artifact_sha256; sha256: e22a0250816d22053fcea9aea187fd3e370deedf30ec9374abc3a0c4c46d3c17; record id: uc-clinical-20260930-source-enigma; fields: status; attributes.artifact_sha256; sha256: 98137d62503a5f20532852f6a20517afeaacd0b0ae8e36dfccc9a48385284528; record id: use-case-brca1-brca2-germline-interpretation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 9681ae92e727dde7a801aec8d4884ec28b009d134a52d806a266f7d3b64bd5bd